TIDMCIZ

RNS Number : 6769B

Cizzle Biotechnology Holdings PLC

05 June 2023

5 June 2023

Cizzle Biotechnology Holdings Plc

("Cizzle Biotechnology", "Cizzle" or the "Company")

Posting of Annual Report and Notice of AGM

Cizzle Biotechnology, the UK-based diagnostics developer, is pleased to announce that copies of the annual report and accounts for the year ended 31 December 2022, together with the notice of Annual General Meeting ("AGM"), have been sent to shareholders and are available for viewing on the Company's website at https://cizzlebiotechnology.com .

The AGM of Cizzle Biotechnology will be held at 11.00 a.m. BST on 28 June 2023 at the offices of Shakespeare Martineau LLP, 6(th) Floor, 60 Gracechurch Street, London, EC3V 0HR.

Enquiries:

 
 Cizzle Biotechnology Holdings     Via IFC Advisory 
  plc 
 Allan Syms (Executive Chairman) 
 
 
 Allenby Capital Limited    +44(0) 20 33285656 
 John Depasquale 
 Alex Brearley 
 
 
 Novum Securities Limited    +44(0) 20 7399 9400 
 Colin Rowbury 
  Jon Bellis 
 
 
 IFC Advisory Limited    +44(0) 20 3934 6630 
 Tim Metcalfe            cizzle@investor-focus.co.uk 
 Florence Chandler

About Cizzle Biotechnology

Cizzle Biotechnology is developing a blood test for the early detection of lung cancer. Cizzle Biotechnology is a spin- out from the University of York, founded in 2006 around the work of Professor Coverley and colleagues. Its proof-of-concept prototype test is based on the ability to detect a stable plasma biomarker, a variant of CIZ1 known as CIZ1B. CIZ1 is a naturally occurring cell nuclear protein involved in DNA replication, and the targeted CIZ1B variant is highly correlated with early-stage lung cancer. For more information, please see https://cizzlebiotechnology.com You can also follow the Company through its twitter account @CizzlePlc and on LinkedIn.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NOANKPBNDBKDPAK

(END) Dow Jones Newswires

June 05, 2023 07:35 ET (11:35 GMT)

Cizzle Biotechnology (LSE:CIZ)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024 Haga Click aquí para más Gráficas Cizzle Biotechnology.
Cizzle Biotechnology (LSE:CIZ)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024 Haga Click aquí para más Gráficas Cizzle Biotechnology.